Analgesia pp 217-249 | Cite as

Glutamate Receptor Ligands

  • V. Neugebauer
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 177)

Abstract

Glutamate acts through a variety of receptors to modulate neurotransmission and neuronal excitability. Glutamate plays a critical role in neuroplasticity as well as in nervous system dysfunctions and disorders. Hyperfunction or dysfunction of glutamatergic neurotransmission also represents a key mechanism of pain-related plastic changes in the central and peripheral nervous system. This chapter will review the classification of glutamate receptors and their role in peripheral and central nociceptive processing. Evidence from preclinical pain models and clinical studies for the therapeutic value of certain glutamate receptor ligands will be discussed.

Keywords

Ionotropic glutamate receptors NMDA and non-NMDA receptor antagonists Metabotropic glutamate receptors Neurotransmission Nociception Plasticity Analgesia Preclinical Clinical 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anwyl R (1999) Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Brain Res Rev 29:83–120PubMedGoogle Scholar
  2. Bardoni R, Torsney C, Tong CK, Prandini M, MacDermott AB (2004) Presynaptic NMDA receptors modulate glutamate release from primary sensory neurons in rat spinal cord dorsal horn. J Neurosci 24:2774–2781PubMedGoogle Scholar
  3. Berrino L, Oliva P, Rossi F, Palazzo E, Nobili B, Maione S (2001) Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system. Naunyn Schmiedebergs Arch Pharmacol 364:437–443PubMedGoogle Scholar
  4. Bhave G, Nadin BM, Brasier DJ, Glauner KS, Shah RD, Heinemann SF, Karim F, Gereau RW IV (2003) Membrane topology of a metabotropic glutamate receptor. J Biol Chem 278:30294–30301PubMedGoogle Scholar
  5. Bird GC, Lash LL, Han JS, Zou X, Willis WD Neugebauer V (2005) PKA-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in amygdala neurons. J Physiol Online 564.3:907–921Google Scholar
  6. Bockaert J, Pin JP(1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18:1723–1729PubMedGoogle Scholar
  7. Bortolotto ZA, Lauri S, Isaac JT, Collingridge GL (2003) Kainate receptors and the induction of mossy fibre long-term potentiation. Philos Trans R Soc Lond B Biol Sci 358:657–666PubMedGoogle Scholar
  8. Carlsson KC, Hoem NO, Moberg ER, Mathisen LC (2004) Analgesic effect of dextromethorphan in neuropathic pain. Acta Anaesthesiol Scand 48:328–336PubMedGoogle Scholar
  9. Carlton SM (2001) Peripheral excitatory amino acids. Curr Opin Pharmacol 1:52–56PubMedGoogle Scholar
  10. Carlton SM, Rees H, Gondesen K Willis WD (1997) Dextrorphan attenuates responses of spinothalamic tract cells in normal and nerve-injured monkeys. Neurosci Lett 229:169–172PubMedGoogle Scholar
  11. Carlton SM, Rees H, Tsuruoka M Willis WD (1998) Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys. Eur J Pain 2:229–238PubMedGoogle Scholar
  12. Cartmell J, Schoepp DD (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75:889–907PubMedGoogle Scholar
  13. Chittajallu R, Braithwaite SP, Clarke VR, Henley JM (1999) Kainate receptors: subunits, synaptic localization and function. Trends Pharmacol Sci 20:26–35PubMedGoogle Scholar
  14. Chizh BA, Headley PM, Tzschentke TM (2001) NMDA receptor antagonists as analgesics: focus on the NR2B subtype. Trends Pharmacol Sci 22:636–642PubMedGoogle Scholar
  15. Cohen SP, Chang AS, Larkin T, Mao J (2004) The intravenous ketamine test: a predictive response tool for oral dextromethorphan treatment in neuropathic pain. Anesth Analg 99:1753–1759PubMedGoogle Scholar
  16. Conn PJ, Niswender CM (2006) mGluR7’s lucky number. Proc Natl Acad Sci U S A 103:251–252PubMedGoogle Scholar
  17. De Blasi A, Conn PJ, Pin J, Nicoletti F (2001) Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci 22:114–120PubMedGoogle Scholar
  18. Dingledine R, Borges K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7–61PubMedGoogle Scholar
  19. Dominguez E, Iyengar S, Shannon HE, Bleakman D, Alt A, Arnold BM, Bell MG, Bleisch TJ, Buckmaster JL, Castano AM, Del Prado M, Escribano A, Filla SA, Ho KH, Hudziak KJ, Jones CK, Martinez-Perez JA, Mateo A, Mathes BM, Mattiuz EL, Ogden AM, Simmons RM, Stack DR, Stratford RE, Winter MA, Wu Z, Ornstein PL (2005) Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain. J Med Chem 48:4200–4203PubMedGoogle Scholar
  20. Du J, Zhou S, Coggeshall RE, Carlton SM (2003) N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors. Neuroscience 118:547–562PubMedGoogle Scholar
  21. Fisher K, Coderre TJ, Hagen NA (2000) Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage 20:358–373PubMedGoogle Scholar
  22. Fundytus ME (2001) Glutamate receptors and nociception. Implications for the drug treatment of pain. CNS Drugs 15:29–58PubMedGoogle Scholar
  23. Galer BS, Lee D, Ma T, Nagle B, Schlagheck TG (2005) MorphiDex[trademark] (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain 115:284–295PubMedGoogle Scholar
  24. Garry EM, Jones E, Fleetwood-Walker SM (2004) Nociception in vertebrates: key receptors participating in spinal mechanisms of chronic pain in animals. Brain Res Brain Res Rev 46:216–224PubMedGoogle Scholar
  25. Gasparini F, Kuhn R, Pin JP (2002) Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr Opin Pharmacol 2:43–49PubMedGoogle Scholar
  26. Gebhart GF (2004) Descending modulation of pain. Neurosci Biobehav Rev 27:729–737PubMedGoogle Scholar
  27. Gerber G, Youn DH, Hsu CH, Isaev D, Randic M (2000a) Spinal dorsal horn synaptic plasticity: involvement of group I metabotropic glutamate receptors. Prog Brain Res 129:115–134PubMedGoogle Scholar
  28. Gerber G, Zhong J, Youn D, Randic M (2000b) Group II and group III metabotropic glutamate receptor agonists depress synaptic transmission in the rat spinal cord dorsal horn. Neuroscience 100:393–406PubMedGoogle Scholar
  29. Gilron I (2001) LY-293558. Eli Lilly and Co. Curr Opin Investig Drugs 2:1273–1278PubMedGoogle Scholar
  30. Gilron I, Max MB, Lee G, Booher SL, Sang CN, Chappell AS, Dionne RA (2000) Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain. Clin Pharmacol Ther 68:320–327PubMedGoogle Scholar
  31. Haberny KA, Paule MG, Scallet AC, Sistare FD, Lester DS, Hanig JP, Slikker W Jr (2002) Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. Toxicol Sci 68:9–17PubMedGoogle Scholar
  32. Han JS Neugebauer V (2005) mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain. Pain 113:211–222PubMedGoogle Scholar
  33. Heinricher MM, Pertovaara A Ossipov MH (2003) Descending modulation after injury. Prog Pain Res Manag 24:251–260Google Scholar
  34. Henriksson KG, Sorensen J (2002) The promise of N-methyl-D-aspartate receptor antagonists in fibromyalgia. Rheum Dis Clin North Am 28:343–351PubMedGoogle Scholar
  35. Hewitt DJ (2003) N-methyl-D-aspartate-enhanced analgesia. Curr Pain Headache Rep 7:43–47PubMedGoogle Scholar
  36. Hu HJ, Bhave G, Gereau RW IV (2002) Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: potential mechanism for thermal hyperalgesia. J Neurosci 22:7444–7452PubMedGoogle Scholar
  37. Jang JH, Kim DW, Sang Nam T, Se Paik K, Leem JW (2004) Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic pain model of the rat. Neuroscience 128:169–176PubMedGoogle Scholar
  38. Jones CK, Eberle EL, Peters SC, Monn JA, Shannon HE (2005) Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing. Neuropharmacology 49:206–218PubMedGoogle Scholar
  39. Karim F, Wang CC, Gereau RW (2001) Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 21:3771–3779PubMedGoogle Scholar
  40. Kilpatrick GJ, Tilbrook GS (2002) Memantine. Merz. Curr Opin Investig Drugs 3:798–806PubMedGoogle Scholar
  41. Kolhekar R, Murphy S, Gebhart GF (1997) Thalamic NMDA receptors modulate inflammation-produced hyperalgesia in the rat. Pain 71:31–40PubMedGoogle Scholar
  42. Lawand NB, Willis WD, Westlund KN (1997) Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats. Eur J Pharmacol 324:169–177PubMedGoogle Scholar
  43. Lee CJ, Bardoni R, Tong CK, Engelman HS, Joseph DJ, Magherini PC, MacDermott AB (2002) Functional expression of AMPA receptors on central terminals of rat dorsal root ganglion neurons and presynaptic inhibition of glutamate release. Neuron 35:135–146PubMedGoogle Scholar
  44. Lei LG, Sun S, Gao YJ, Zhao ZQ, Zhang YQ (2004) NMDA receptors in the anterior cingulated cortex mediate pain-related aversion. Exp Neurol 189:413–421PubMedGoogle Scholar
  45. Lerma J (2003) Roles and rules of kainate receptors in synaptic transmission. Nat Rev Neurosci 4:481–495PubMedGoogle Scholar
  46. Lerma J, Paternain AV, Rodriguez-Moreno A, Lopez-Garcia JC (2001) Molecular physiology of kainate receptors. Physiol Rev 81:971–998PubMedGoogle Scholar
  47. Lesage ASJ (2004) Role of group I metabotropic glutamate receptors mGlu1 and mGlu5 in nociceptive signalling. Curr Neuropharmacol 2:363–393Google Scholar
  48. Li W, Neugebauer V (2004a) Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons. J Neurophysiol 91:13–24PubMedGoogle Scholar
  49. Li W, Neugebauer V (2004b) Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain. Pain 110:112–122PubMedGoogle Scholar
  50. Low SJ, Roland CL (2004) Review of NMDA antagonist-induced neurotoxicity and implications for clinical development. Int J Clin Pharmacol Ther 42:1–14PubMedGoogle Scholar
  51. Lu CR, Willcockson HH, Phend KD, Lucifora S, Darstein M, Valtschanoff JG, Rustioni A (2005) Ionotropic glutamate receptors are expressed in GABAergic terminals in the rat superficial dorsal horn. J Comp Neurol 486:169–178PubMedGoogle Scholar
  52. Maj M, Bruno V, Dragic Z, Yamamoto R, Battaglia G, Inderbitzin W, Stoehr N, Stein T, Gasparini F, Vranesic I (2003) (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology 45:895–906PubMedGoogle Scholar
  53. Maione S, Marabese I, Leyva J, Palazzo E, de Novellis V, Rossi F (1998) Characterisation of mGluRs which modulate nociception in the PAG of the mouse. Neuropharmacology 37:1475–1483PubMedGoogle Scholar
  54. Maione S, Oliva P, Marabese I, Palazzo E, Rossi F, Berrino L, Rossi F, Filippelli A (2000) Periaqueductal gray matter metabotropic glutamate receptors modulate for malin-induced nociception. Pain 85:183–189PubMedGoogle Scholar
  55. Mayer ML (2005) Glutamate receptor ion channels. Curr Opin Neurobiol 15:282–288PubMedGoogle Scholar
  56. Mayer ML, Armstrong N (2004) Structure and function of glutamate receptor ion channels. Annu Rev Physiol 66:161–181PubMedGoogle Scholar
  57. McCartney CJ, Sinha A, Katz J (2004) Aqualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia. Anesth Analg 98:1385–1400PubMedGoogle Scholar
  58. McNearney T, Speegle D, Lawand N, Lisse J, Westlund KN (2000) Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 27:739–745PubMedGoogle Scholar
  59. McRoberts JA, Coutinho SV, Marvizon JC, Grady EF, Tognetto M, Sengupta JN, Ennes HS, Chaban VV, Amadesi S, Creminon C (2001) Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 120:1737–1748PubMedGoogle Scholar
  60. Michaelis EK (1998) Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 54:369–415PubMedGoogle Scholar
  61. Mitsukawa K, Yamamoto R, Ofner S, Nozulak J, Pescott O, Lukic S, Stoehr N, Mombereau C, Kuhn R, McAllister KH, van der Putten H, Cryan JF, Flor PJ (2005) A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proc Natl Acad Sci U S A 102:18712–18717PubMedGoogle Scholar
  62. Moore KA, Baba H, Woolf CJ (2000) Synaptic transmission and plasticity in the superficial dorsal horn. Prog Brain Res 129:63–80PubMedGoogle Scholar
  63. More JC, Nistico R, Dolman NP, Clarke VR, Alt AJ, Ogden AM, Buelens FP, Troop HM, Kelland EE, Pilato F, Bleakman D, Bortolotto ZA, Collingridge GL, Jane DE (2004) Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist. Neuropharmacology 47:46–64PubMedGoogle Scholar
  64. Nagy GG, Watanabe M, Fukaya M, Todd AJ (2004) Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-D-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique. Eur J Neurosci 20:3301–3312PubMedGoogle Scholar
  65. Nakazato E, Kato A, Watanabe S (2005) Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model. Pharmacology 73:8–14PubMedGoogle Scholar
  66. Neto FL, Castro-Lopes JM (2000) Antinociceptive effect of a group II metabotropic glutamate receptor antagonist in the thalamus of monoarthritic rats. Neurosci Lett 296:25–28PubMedGoogle Scholar
  67. Neugebauer V (2001) Metabotropic glutamate receptors: novel targets for pain relief. Expert Rev Neurother 1:207–224Google Scholar
  68. Neugebauer V (2002) Metabotropic glutamate receptors—important modulators of nociception and pain behavior. Pain 98:1–8PubMedGoogle Scholar
  69. Neugebauer V, Chen P-SWillis WD (2000) Groups II and III metabotropic glutamate receptors differentially modulate brief and prolonged nociception in primate STT cells. J Neurophysiol 84:2998–3009PubMedGoogle Scholar
  70. Neugebauer V, Chen PS, Willis WD (1999) Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells. J Neurophysiol 82:272–282PubMedGoogle Scholar
  71. Neugebauer V, Li W, Bird GC, Bhave G Gereau RW (2003) Synaptic plasticity in the amygdala in amodel of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5. J Neurosci 23:52–63PubMedGoogle Scholar
  72. Neugebauer V, Li W, Bird GC Han JS (2004) The amygdala and persistent pain. Neuroscientist 10:221–234PubMedGoogle Scholar
  73. Neugebauer V Carlton SM (2002) Peripheral metabotropic glutamate receptors as drug targets for pain relief. Expert Opin Ther Targets 6:349–361PubMedGoogle Scholar
  74. Nishimura W, Muratani T, Tatsumi S, Sakimura K, Mishina M, Minami T, Ito S (2004) Characterization of N-methyl-D-aspartate receptor subunits responsible for postoperative pain. Eur J Pharmacol 503:71–75PubMedGoogle Scholar
  75. Nishiyama T, Kawasaki-Yatsugi S, Yamaguchi T, Hanaoka K (2004) Spinal neurotoxicity and tolerance after repeated intrathecal administration of YM 872, an AMPA receptor antagonist, in rats. J Anesth 18:113–117PubMedGoogle Scholar
  76. Ong CK, Lirk P, Seymour RA, Jenkins BJ (2005) The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis. Anesth Analg 100:757–773PubMedGoogle Scholar
  77. Palecek J, Neugebauer V, Carlton SM, Iyengar S, Willis WD (2004) The effect of a kainate GluR5 receptor antagonist on responses of spinothalamic tract neurons in a model of peripheral neuropathy in primates. Pain 111:151–161PubMedGoogle Scholar
  78. Parsons CG (2001) NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol 429:71–78PubMedGoogle Scholar
  79. Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist—a review of preclinical data. Neuropharmacology 38:735–767PubMedGoogle Scholar
  80. Porreca F, Ossipov MH, Gebhart GF (2002) Chronic pain and medullary descending facilitation. Trends Neurosci 25:319–325PubMedGoogle Scholar
  81. Ren K, Dubner R (2002) Descending modulation in persistent pain: an update. Pain 100:1–6PubMedGoogle Scholar
  82. Ruscheweyh R, Sandkuhler J (2002) Role of kainate receptors in nociception. Brain Res Brain Res Rev 40:215–222PubMedGoogle Scholar
  83. Salt TE (2002) Glutamate receptor functions in sensory relay in the thalamus. Philos Trans R Soc Lond B Biol Sci 357:1759–1766PubMedGoogle Scholar
  84. Salt TE, Binns KE (2000) Contributions of mGlu1 and mGlu5 receptors to interactions with N-methyl-D-aspartate receptor-mediated responses and nociceptive sensory responses of rat thalamic neurons. Neuroscience 100:375–380PubMedGoogle Scholar
  85. Salt TE, Eaton SA, Turner JP (1996) Characterization of the metabotropic glutamate receptors (mGluRs) which modulate GABA-mediated inhibition in the ventrobasal thalamus. Neurochem Int 29:317–322PubMedGoogle Scholar
  86. Sang CN, Hostetter MP, Gracely RH, Chappell AS, Schoepp DD, Lee G, Whitcup S, Caruso R, Max MB (1998) AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans. Anesthesiology 89:1060–1067PubMedGoogle Scholar
  87. Sang CN, Ramadan NM, Wallihan RG, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Johnson KW, Phebus LA, Bleakman D, Ornstein PL, Arnold B, Tepper SJ, Vandenhende F (2004) LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia 24:596–602PubMedGoogle Scholar
  88. Schaible HG, Ebersberger A, von Banchet GS (2002) Mechanisms of pain in arthritis. Ann N Y Acad Sci 966:343–354PubMedGoogle Scholar
  89. Schoepp DD, Jane DE, Monn JA (1999) Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38:1431–1476PubMedGoogle Scholar
  90. Shipe WD, Wolkenberg SE, Williams DL Jr, Lindsley CW (2005) Recent advances in positive allosteric modulators of metabotropic glutamate receptors. Curr Opin Drug Discov Devel 8:449–457PubMedGoogle Scholar
  91. Simmons RM, Li DL, Hoo KH, Deverill M, Ornstein PL, Iyengar S (1998) Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology 37:25–36PubMedGoogle Scholar
  92. Simmons RM, Webster AA, Kalra AB, Iyengar S (2002) Group IImGluR receptor agonists are effective in persistent and neuropathic pain models in rats. Pharmacol Biochem Behav 73:419–427PubMedGoogle Scholar
  93. Soliman AC, Yu JSC, Coderre TJ (2005) mGlu and NMDA receptor contributions to capsaicin-induced thermal and mechanical hypersensitivity. Neuropharmacology 48:325–332PubMedGoogle Scholar
  94. Stanfa LC, Dickenson AH (1999) The role of non-N-methyl-D-aspartate ionotropic glutamate receptors in the spinal transmission of nociception in normal animals and animals with carrageenan inflammation. Neuroscience 93:1391–1398PubMedGoogle Scholar
  95. Sutton JL, Maccecchini ML, Kajander KC (1999) The kainate receptor antagonist 2S,4R-4-methylglutamate attenuates mechanical allodynia and thermal hyperalgesia in a rat model of nerve injury. Neuroscience 91:283–292PubMedGoogle Scholar
  96. Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, Schoepp DD (2005) Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 4:131–144PubMedGoogle Scholar
  97. Thomas NK, Wright RA, Howson PA, Kingston AE, Schoepp DD, Jane DE (2001) (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology 40:311–318PubMedGoogle Scholar
  98. Tolle TR, Berthele A, Zieglgansberger W, Seeburg PH, Wisden W (1993) The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci 13:5009–5028PubMedGoogle Scholar
  99. Urban MO, Coutinho SV, Gebhart GF (1999) Involvement of excitatory amino acid receptors and nitric oxide in the rostral ventromedial medulla in modulating secondary hyperalgesia produced by mustard oil. Pain 81:45–55PubMedGoogle Scholar
  100. Vaccarino AL, Clemmons HR, Mader J, Magnusson JE (1997) A role of periaqueductal grey NMDA receptors in mediating formalin-induced pain in the rat. Neurosci Lett 236:117–119PubMedGoogle Scholar
  101. Vanegas H, Schaible HG (2004) Descending control of persistent pain: inhibitory or facilitatory? Brain Res Brain Res Rev 46:295–309PubMedGoogle Scholar
  102. Varney MA Gereau RW (2002) Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics. Curr Drug Targets 1:215–225Google Scholar
  103. Varty GB, Grilli M, Forlani A, Fredduzzi S, Grzelak ME, Guthrie DH, Hodgson RA, Lu SX, Nicolussi E, Pond AJ, Parker EM, Hunter JC, Higgins GA, Reggiani A, Bertorelli R (2005) The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology (Berl) 179:207–217PubMedGoogle Scholar
  104. Von Bergen NH, Subieta A, Brennan TJ (2002) Effect of intrathecal non-NMDA EAA receptor antagonist LY293558 in rats: a new class of drugs for spinal anesthesia. Anesthesiology 97:177–182Google Scholar
  105. Wallace MS, Rowbotham MC, Katz NP, Dworkin RH, Dotson RM, Galer BS, Rauck RL, Backonja MM, Quessy SN, Meisner PD (2002) A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology 59:1694–1700PubMedGoogle Scholar
  106. Wang CX, Shuaib A (2005) NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Curr Drug Targets CNS Neurol Disord 4:143–151PubMedGoogle Scholar
  107. Wei F, Wang GD, Kerchner GA, Kim SJ, Xu HM, Chen ZF, Zhuo M (2001) Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci 4:164–169PubMedGoogle Scholar
  108. Wei F, Qiu CS, Kim SJ, Muglia L, Maas J, Pineda VV, Xu HM, Chen ZF, Storm DR (2002) Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases. Neuron 36:713–726PubMedGoogle Scholar
  109. Weinbroum AA, Rudick V, Paret G, Ben-Abraham R (2000) The role of dextromethorphan in pain control. Can J Anaesth 47:585–596PubMedGoogle Scholar
  110. Willis WD (2001) Role of neurotransmitters in sensitization of pain responses. Ann N Y Acad Sci 933:142–156PubMedGoogle Scholar
  111. Willis WD, Coggeshall RE (2004) Sensory mechanisms of the spinal cord. Kluwer Academic/Plenum, New YorkGoogle Scholar
  112. Wollmuth LP, Sobolevsky AI (2004) Structure and gating of the glutamate receptor ion channel. Trends Neurosci 27:321–328PubMedGoogle Scholar
  113. Woolf CJ (2004) Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 140:441–451PubMedGoogle Scholar
  114. Yang D, Gereau RW(2002) Peripheral group II metabotropic glutamate receptors (mGluR2/3) regulate prostaglandin E2-mediated sensitization of capsaicin responses and thermal nociception. J Neurosci 22:6388–6393PubMedGoogle Scholar
  115. Yang D, Gereau RW (2003) Peripheral group II metabotropic glutamate receptors mediate endogenous anti-allodynia in inflammation. Pain 106:411–417PubMedGoogle Scholar
  116. Youn DH, Randic M (2004) Modulation of excitatory synaptic transmission in the spinal substantia gelatinosa of mice deficient in the kainate receptor GluR5 and/or GluR6 subunit. J Physiol 555:683–698PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • V. Neugebauer
    • 1
  1. 1.Department of Neuroscience and Cell BiologyThe University of Texas Medical BranchGalvestonUSA

Personalised recommendations